Brackett Partners - Strategic Intelligence

Q: What does Brackett Partners do?

Brackett Partners is a strategic advisory firm backed by AI-powered predictive intelligence, with three sides: Advisory (customer-validated strategy for leadership teams), Agency (Digital CMO leadership and marketing execution at scale with Hawke Media), and M&A Advisory (sell-side M&A advisory in partnership with Britehorn Securities, Member FINRA/SIPC). The firm also serves the public sector at the state and federal level.

Q: How do Brackett engagements work?

One way of working, every engagement: Diagnose (evidence first — a structured, customer-validated read), Direct (findings become ranked priorities with defined decision points), and Deliver (Brackett stays accountable to the roadmap). No packages or pre-scoped offers — every engagement is shaped after a conversation and gated phase by phase.

Q: Who does Brackett Partners serve?

Clients range from venture-backed companies to Fortune-ranked enterprises to state and federal institutions, across Healthcare & MedTech, Industrial & Manufacturing, Consumer & Hospitality, Technology & Venture-Backed, and the Public Sector.

Q: What is CVX SCAN?

CVX SCAN® is a Brackett Advisory service powered by the Luminas CVX SCAN® methodology: a 4-6 week structured, qualitative customer value assessment that identifies where a company holds differential value and which customer-driven growth opportunities to prioritize.

Q: What is Brackett's Predictive Intelligence capability?

AI-powered market research and analytics delivered in partnership with OSG Analytics: ASEMAP future-behavior modeling, choice modeling with willingness-to-pay curves and market simulation, adoption drivers analysis, and real-time analytics with segments delivered into the client's CRM.

Brackett Partners

All Case Studies

Life SciencesMarket Repositioning

Medical Device Market Repositioning

Fortune 500 Medical Device Company|Fortune 500 / Enterprise

85%

Brand loyalty retained

3x

Reimbursement approval rate

18mo

Accelerated market entry

$240M

First-year revenue target

The Challenge

Needed to transition from Phasix to GalaFlex, defend brand loyalty, improve reimbursement access, and differentiate clinically in a competitive market.

brand transitionreimbursement denialspatient accessclaims differentiationclinical outcomescompetition

The Solution

Market Intelligence + Positioning Strategy + Access Strategy

Validated customer segments
Quantified switching barriers
Differentiated value proposition
Reimbursement optimization roadmap
Payer engagement plan

The Results

Retained loyalty while improving reimbursement success and accelerating market entry.

85%

Brand loyalty retained

3x

Reimbursement approval rate

18mo

Accelerated market entry

$240M

First-year revenue target

Functional Areas

Go-to-MarketPositioningMarket Access

Want the Full Implementation Playbook?

Get the complete case study with detailed methodology, implementation timeline, specific frameworks used, and lessons learned.

Sound Familiar?

This Case Study May Be Relevant If You're Saying...

1

"We need to reposition a medical device"

2

"Reimbursement is slowing uptake"

3

"We need stronger claims differentiation"

4

"We are switching or relaunching a brand"

Discuss Your Challenge

Ready to See Results Like These?

Let's Discuss Your Challenge

Every engagement starts with understanding your specific situation. Request a consultation to explore how we can help.

Request Consultation